- Sweden
- /
- Medical Equipment
- /
- OM:VIMIAN
Vimian Group Third Quarter 2024 Earnings: €0.004 loss per share (vs €0.016 profit in 3Q 2023)
Vimian Group (STO:VIMIAN) Third Quarter 2024 Results
Key Financial Results
- Revenue: €87.6m (up 9.6% from 3Q 2023).
- Net loss: €2.13m (down by 129% from €7.43m profit in 3Q 2023).
- €0.004 loss per share (down from €0.016 profit in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Vimian Group Earnings Insights
Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Medical Equipment industry in Sweden.
Performance of the Swedish Medical Equipment industry.
The company's shares are up 5.4% from a week ago.
Risk Analysis
Before you take the next step you should know about the 2 warning signs for Vimian Group that we have uncovered.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About OM:VIMIAN
Reasonable growth potential and fair value.
